Standout Papers

Fenfluramine hydrochloride for the treatment of seizures in Dravet syndrome: a randomised, double-blind, p... 2019 2026 2021 2023 232
  1. Fenfluramine hydrochloride for the treatment of seizures in Dravet syndrome: a randomised, double-blind, placebo-controlled trial (2019)
    Lieven Lagae, Joseph Sullivan et al. The Lancet

Immediate Impact

29 standout
Sub-graph 1 of 14

Citing Papers

mTOR and neuroinflammation in epilepsy: implications for disease progression and treatment
2024 Standout
2024 Update in Heart Failure
2024 Standout
2 intermediate papers

Works of Arun Mistry being referenced

Fenfluramine for Treatment-Resistant Seizures in Patients With Dravet Syndrome Receiving Stiripentol-Inclusive Regimens
2019
Fenfluramine hydrochloride for the treatment of seizures in Dravet syndrome: a randomised, double-blind, placebo-controlled trial
2019 Standout

Author Peers

Author Last Decade Papers Cites
Arun Mistry 389 271 53 153 8 531
Lars‐Martin Wiklund 145 214 33 68 16 537
Stephen Trevick 152 88 60 102 8 561
Julius D. Metrakos 235 123 19 122 18 518
Jesper Erdal 240 180 55 104 18 541
Renato D’Alonzo 176 168 63 78 9 468
PAUL G. BELAU 274 143 19 94 8 583
Camille Orman 362 218 24 86 10 463
E Völzke 398 217 7 166 16 515
W. C. Wiser 193 78 17 104 12 467
Fabienne Dietrich Alber 224 286 24 53 9 498

All Works

Loading papers...

Rankless by CCL
2026